PureTech Health plc (LON:PRTC)

PureTech Health Statistics

Total Valuation

PureTech Health has a market cap or net worth of GBP 323.37 million. The enterprise value is 195.89 million.

Market Cap	323.37M
Enterprise Value	195.89M

Important Dates

The next estimated earnings date is Wednesday, April 29, 2026.

Earnings Date	Apr 29, 2026
Ex-Dividend Date	n/a

Share Statistics

PureTech Health has 241.68 million shares outstanding. The number of shares has decreased by -11.33% in one year.

Current Share Class	241.68M
Shares Outstanding	241.68M
Shares Change (YoY)	-11.33%
Shares Change (QoQ)	-1.00%
Owned by Insiders (%)	3.58%
Owned by Institutions (%)	72.98%
Float	167.88M

Valuation Ratios

The trailing PE ratio is 9.09.

PE Ratio	9.09
Forward PE	n/a
PS Ratio	69.32
PB Ratio	1.20
P/TBV Ratio	1.18
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	5.30
EV / Sales	41.99
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.68

Financial Position

The company has a current ratio of 8.49, with a Debt / Equity ratio of 0.44.

Current Ratio	8.49
Quick Ratio	8.35
Debt / Equity	0.44
Debt / EBITDA	n/a
Debt / FCF	-1.63
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 9.44% and return on invested capital (ROIC) is -53.21%.

Return on Equity (ROE)	9.44%
Return on Assets (ROA)	-12.95%
Return on Invested Capital (ROIC)	-53.21%
Return on Capital Employed (ROCE)	-22.90%
Revenue Per Employee	83,300
Profits Per Employee	660,533
Employee Count	56
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

In the past 12 months, PureTech Health has paid 2.23 million in taxes.

Income Tax	2.23M
Effective Tax Rate	8.76%

Stock Price Statistics

The stock price has decreased by -2.46% in the last 52 weeks. The beta is 0.70, so PureTech Health's price volatility has been lower than the market average.

Beta (5Y)	0.70
52-Week Price Change	-2.46%
50-Day Moving Average	126.01
200-Day Moving Average	128.93
Relative Strength Index (RSI)	63.07
Average Volume (20 Days)	483,849

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PureTech Health had revenue of GBP 4.66 million and earned 36.99 million in profits. Earnings per share was 0.15.

Revenue	4.66M
Gross Profit	-35.63M
Operating Income	-85.69M
Pretax Income	25.51M
Net Income	36.99M
EBITDA	-84.46M
EBIT	-85.69M
Earnings Per Share (EPS)	0.15

Balance Sheet

The company has 241.80 million in cash and 119.39 million in debt, with a net cash position of 122.41 million or 0.51 per share.

Cash & Cash Equivalents	241.80M
Total Debt	119.39M
Net Cash	122.41M
Net Cash Per Share	0.51
Equity (Book Value)	269.35M
Book Value Per Share	1.14
Working Capital	221.75M

Cash Flow

In the last 12 months, operating cash flow was -73.21 million and capital expenditures -8,029, giving a free cash flow of -73.21 million.

Operating Cash Flow	-73.21M
Capital Expenditures	-8,029
Free Cash Flow	-73.21M
FCF Per Share	-0.30

Margins

Gross Margin	n/a
Operating Margin	-1,837.01%
Pretax Margin	546.82%
Profit Margin	792.96%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PureTech Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	11.33%
Shareholder Yield	11.33%
Earnings Yield	11.44%
FCF Yield	-22.64%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

PureTech Health has an Altman Z-Score of 1.44 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.44
Piotroski F-Score	4